Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)
Crossref DOI link: https://doi.org/10.1186/s12885-015-1354-2
Published Online: 2015-05-06
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Camerini, Andrea
Puccetti, Cheti
Donati, Sara
Valsuani, Chiara
Petrella, Maria Cristina
Tartarelli, Gianna
Puccinelli, Paolo
Amoroso, Domenico
License valid from 2015-05-06